Drug Price Trends for PHENASEPTIC

Average Pharmacy Cost for PHENASEPTIC

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
PHENASEPTIC 1.4% SPRAY	00536-1228-58	0.01313	ML	2024-12-18
PHENASEPTIC 1.4% SPRAY	00536-1228-58	0.01311	ML	2024-11-20
PHENASEPTIC 1.4% SPRAY	00536-1228-58	0.01307	ML	2024-10-23
PHENASEPTIC 1.4% SPRAY	00536-1228-58	0.01277	ML	2024-09-18
PHENASEPTIC 1.4% SPRAY	00536-1228-58	0.01279	ML	2024-08-21
PHENASEPTIC 1.4% SPRAY	00536-1228-58	0.01256	ML	2024-07-17

PHENASEPTIC Market Analysis and Financial Projection

Phenobarbital Market Analysis and Price Projections

Introduction to Phenobarbital

Phenobarbital, a medication belonging to the class of barbiturates, is primarily used as an anti-epileptic drug to control and prevent seizures in various forms of epilepsy. It works by slowing down the activity in the brain and nervous system, thereby reducing the occurrence of seizures. Additionally, it is sometimes used as a sedative or for the treatment of withdrawal symptoms associated with alcohol or drug dependence[1].

Global Phenobarbital Market Size and Growth

The global phenobarbital market is estimated to be valued at US$ 1.58 billion in 2023 and is expected to reach US$ 2.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5% from 2023 to 2030. This growth is driven by the widespread use of phenobarbital as an anticonvulsant medication, particularly in developing countries where it remains an affordable and accessible option[1].

Regional Insights

• North America: This region dominates the phenobarbital market and is expected to remain the largest regional market. The increasing incidence of traumatic brain injuries from accidents is a major factor driving higher phenobarbital consumption in this region[1].
• Asia Pacific: This region presents lucrative opportunities due to its massive patient population and improving access to healthcare. Countries like India and China, with their healthcare initiatives, are boosting the regional demand for phenobarbital[1].

Market Drivers

• Increasing Prevalence of Epilepsy: The rising prevalence of epilepsy and other seizure disorders is a key driver for the market growth of phenobarbital. Phenobarbital remains one of the most commonly prescribed anti-seizure medications[1].
• Growing Demand for Anticonvulsant Medications: The increasing demand for effective anticonvulsant medications, especially in regions with limited access to newer drugs, drives the market growth[1].
• Aging Population: An increasing elderly population is expected to drive the demand for phenobarbital as older adults are more susceptible to seizures[1].

Market Restraints

• Regulatory Restrictions: Strict regulations regarding the use of phenobarbital due to its high addiction potential are expected to hamper market growth. Many countries have tightened restrictions on phenobarbital prescriptions[1].
• Side Effects and Alternative Drugs: The adverse effects associated with the use of phenobarbital and the development of alternative anti-epileptic drugs pose challenges to the market growth[1].

Market Opportunities

• Generic Formulations: Generic formulations of phenobarbital are witnessing rising demand due to their cost-effectiveness compared to branded drugs[1].
• Research and Development: Research into developing analogue drugs with lower side effects and improving agriculture and production techniques to overcome raw material supply constraints presents potential opportunities[1].
• Alternative Delivery Forms: Development of easy-to-administer alternative delivery forms may further help in market growth[1].

Price Projections and Inflation

While specific price projections for phenobarbital are not detailed in the sources, the broader pharmaceutical market context provides some insights:

• Pharmaceutical Price Inflation: According to Vizient's summer 2024 Pharmacy Market Outlook, drug price inflation rates for pharmaceuticals are estimated to be 3.81% in 2025. This inflation is driven by factors such as increases in specialty and expensive medications, new drug approvals, and expanded indications[2].

Given the general trend in pharmaceutical price inflation, it is reasonable to expect that the prices of phenobarbital could also see a moderate increase, although this would be influenced by the specific market dynamics and regulatory environment surrounding this drug.

Competitive Landscape

The global phenobarbital market includes key players such as Sanofi, Pfizer Inc., Novartis AG, H. Lundbeck A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Cipla Ltd., and Par Pharmaceutical. These companies are focused on minimizing the adverse effects associated with phenobarbital and developing newer drugs to maintain a competitive edge[1].

Recent Developments and Trends

• New Product Launches: There is a continuous effort to launch new products and formulations that are more effective and have fewer side effects.
• Agreements and Collaborations: Companies are engaging in agreements and collaborations to enhance research and development, and to expand their market presence[1].

Key Takeaways

• The global phenobarbital market is expected to grow significantly due to its widespread use in treating epilepsy and other seizure disorders.
• North America and Asia Pacific are key regions driving market growth.
• Regulatory restrictions and the development of alternative drugs are significant challenges.
• Generic formulations and research into new delivery forms offer potential opportunities.
• Pharmaceutical price inflation trends suggest moderate price increases in the future.

FAQs

1. What is the primary use of phenobarbital?

   • Phenobarbital is primarily used as an anti-epileptic drug to control and prevent seizures in various forms of epilepsy.

2. What is the projected market size of the global phenobarbital market by 2030?

   • The global phenobarbital market is expected to reach US$ 2.23 billion by 2030.

3. Which regions are driving the growth of the phenobarbital market?

   • North America and Asia Pacific are the key regions driving the growth of the phenobarbital market.

4. What are the main challenges facing the phenobarbital market?

   • The main challenges include strict regulatory restrictions due to its high addiction potential and the development of alternative anti-epileptic drugs.

5. What opportunities exist for the growth of the phenobarbital market?

   • Opportunities include the rising demand for generic formulations, research into developing analogue drugs with lower side effects, and the development of alternative delivery forms.

Cited Sources

1. Coherent Market Insights - Phenobarbital Market Size, Trends and Forecast to 2030
2. TechTarget - Vizient estimates a 3.81% inflation in drug prices in 2025
3. House Oversight Committee - Drug Pricing Investigation
4. GlobeNewswire - Phenol Market is Set to Surge at 4.8% CAGR, Reach US$ 41.77 Billion by 2034
5. Newron Pharmaceuticals - vL Report 25MAR24.pdf